HIV-associated Lipodystrophy Syndrome: A Review of Clinical Aspects
Approximately two years after the introduction of highly active antiretroviral therapy for the treatment of HIV infection, body shape changes and metabolic abnormalities were increasingly observed. Initially, these were ascribed to protease inhibitors, but it is now clear that nucleoside reverse tra...
Saved in:
Main Authors: | Jean-Guy Baril, Patrice Junod, Roger LeBlanc, Harold Dion, Rachel Therrien, François Laplante, Julian Falutz, Pierre Côté, Marie-Nicole Hébert, Richard Lalonde, Normand Lapointe, Dominic Lévesque, Lyse Pinault, Danielle Rouleau, Cécile Tremblay, Benoît Trottier, Sylvie Trottier, Chris Tsoukas, Karl Weiss |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2005-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2005/303141 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Improving diagnosis and management of genetic lipodystrophy
by: Milena Teles, et al.
Published: (2025-01-01) -
Patient Care and Support Measures Overcome Reluctance to Initiate New Regimen Containing Enfuvirtide
by: Benoit Trottier
Published: (2007-01-01) -
Canadian Consensus Guidelines for the Optimal Use of Etravirine in the Treatment of HIV-Infected Adults
by: Marianne Harris, et al.
Published: (2009-01-01) -
Disorders of Adipose Tissue and Lipodystrophies: Causes, Consequences, and Treatment Perspectives
by: Rosińska Kamila Rosińska, et al.
Published: (2025-02-01) -
Could Metabolic Syndrome, Lipodystrophy, and Aging Be Mesenchymal Stem Cell Exhaustion Syndromes?
by: Eduardo Mansilla, et al.
Published: (2011-01-01)